Literature DB >> 35831274

Spinal cord untethering and midline myelotomy for delayed, symptomatic post-traumatic syringomyelia due to retained ballistic fragments: case report.

Tej D Azad1, Joshua Materi2, Brian Y Hwang2, Dimitrios Mathios2, Kurt R Lehner2, Landon Hansen2, Lydia J Bernhardt2, Yuanxuan Xia2, Pavan P Shah2, Nivedha V Kannapadi2, Nicholas Theodore2.   

Abstract

INTRODUCTION: Post-traumatic syringomyelia is an uncommon complication after traumatic spinal cord injury. This case study details our decision-making and surgical approach for a patient with symptomatic post-traumatic syringomyelia after sustaining a gunshot wound. CASE
PRESENTATION: A 24-year-old man with past medical history of distant American Spinal Injury Association Impairment Grade B spinal cord injury due to ballistic injury developed delayed post-traumatic syringomyelia, resulting in unilateral sensory loss and left upper extremity weakness. CT and MR imaging revealed a syrinx spanning his cervical and thoracic spine causing significant spinal cord compression. To relieve achieve decompression and restore CSF flow dynamics, we performed a bony extradural decompression, bullet fragment extraction, spinal cord untethering, and midline myelotomy. Postoperatively, the patient demonstrated clinical and radiographical improvement. DISCUSSION: Post-traumatic syringomyelia is potentially morbid sequalae of spinal cord injuries. Suspicion for post-traumatic syringomyelia should be maintained in patients with delayed, progressive neurologic deficits. In this setting, surgical intervention may require extradural and intradural procedures to mitigate neural compression along the dilated central canal by the syrinx.
© 2022. The Author(s), under exclusive licence to International Spinal Cord Society.

Entities:  

Mesh:

Year:  2022        PMID: 35831274      PMCID: PMC9279308          DOI: 10.1038/s41394-022-00533-7

Source DB:  PubMed          Journal:  Spinal Cord Ser Cases        ISSN: 2058-6124


  34 in total

1.  A critical appraisal of drainage in syringomyelia.

Authors:  S Sgouros; B Williams
Journal:  J Neurosurg       Date:  1995-01       Impact factor: 5.115

2.  Progressive post-traumatic cystic and non-cystic myelopathy.

Authors:  R Edgar; P Quail
Journal:  Br J Neurosurg       Date:  1994       Impact factor: 1.596

3.  The characteristics of posttraumatic syringomyelia.

Authors:  J Krebs; H G Koch; K Hartmann; A Frotzler
Journal:  Spinal Cord       Date:  2015-12-01       Impact factor: 2.772

4.  A lumped-parameter model of the cerebrospinal system for investigating arterial-driven flow in posttraumatic syringomyelia.

Authors:  N S J Elliott; D A Lockerby; A R Brodbelt
Journal:  Med Eng Phys       Date:  2010-09-15       Impact factor: 2.242

5.  Post-traumatic syringomyelia: a review of the cases presenting in a regional spinal injuries unit in the north east of England over a 5-year period.

Authors:  Aine M Carroll; Paula Brackenridge
Journal:  Spine (Phila Pa 1976)       Date:  2005-05-15       Impact factor: 3.468

6.  Time course of syringomyelia resolution following decompression of Chiari malformation Type I.

Authors:  Nicholas M Wetjen; John D Heiss; Edward H Oldfield
Journal:  J Neurosurg Pediatr       Date:  2008-02       Impact factor: 2.375

Review 7.  Civilian gunshot injuries of the spinal cord: a systematic review of the current literature.

Authors:  Gursukhman S Sidhu; Arvindera Ghag; Vanessa Prokuski; Alexander R Vaccaro; Kristen E Radcliff
Journal:  Clin Orthop Relat Res       Date:  2013-12       Impact factor: 4.176

8.  Posttraumatic spinal cord tethering and syringomyelia: surgical treatment and long-term outcome.

Authors:  Scott P Falci; Charlotte Indeck; Daniel P Lammertse
Journal:  J Neurosurg Spine       Date:  2009-10

9.  Posttraumatic syringomyelia: the British Columbia experience.

Authors:  H A Anton; J F Schweigel
Journal:  Spine (Phila Pa 1976)       Date:  1986-11       Impact factor: 3.468

10.  Post-traumatic syringomyelia.

Authors:  M Asano; K Fujiwara; K Yonenobu; K Hiroshima
Journal:  Spine (Phila Pa 1976)       Date:  1996-06-15       Impact factor: 3.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.